Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 75.90
-0.28 (-0.37%)
At close: Jan 16, 2026
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 30.98 billion as of January 16, 2026. Its market cap has increased by 6.67% in one year.
Market Cap
30.98B
Enterprise Value
30.30B
Revenue
3.34B
Ranking
n/a
PE Ratio
32.86
Stock Price
75.90
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 30.98B, an increase of 115.75%. That is a compound annual growth rate of 13.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 30.98B | -9.30% |
| Dec 31, 2025 | 34.16B | 14.44% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 412.15B |
| WuXi AppTec | 311.06B |
| Shenzhen Mindray Bio-Medical Electronics | 243.32B |
| Sichuan Biokin Pharmaceutical | 130.12B |
| Shanghai United Imaging Healthcare | 112.20B |
| Aier Eye Hospital Group | 105.78B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.78B |
| Yunnan Baiyao Group Co.,Ltd | 100.28B |